Leonardo DRS Announces Financial Results for Third Quarter 2023
- None.
- None.
-
Revenue:
$703 million -
Net Earnings:
$47 million -
Adjusted EBITDA:
$82 million -
Diluted EPS:
$0.18 -
Adjusted Diluted EPS:
$0.20 -
Bookings:
(book-to-bill ratio of 1.5x)$1.1 billion -
Backlog:
$4.7 billion -
Subsequent to Q3, the company was awarded an over
contract for the electric power and propulsion system on the remaining seven Columbia Class submarines$3 billion - Updates 2023 guidance to narrow the ranges for revenue and adjusted EBITDA and raise the range for adjusted diluted EPS
CEO Commentary
“Leonardo DRS delivered another quarter of excellent results as evidenced by our accelerating organic growth, robust bookings and solid profit generation. The strength of our diverse and differentiated technology, customer and program portfolio is clearly reflected in our financial results. Furthermore, our consistent execution throughout the year positions us well to meet our full year commitments,” said Bill Lynn, Chairman and CEO of Leonardo DRS.
Summary Financial Results
(In millions, except per share amounts) |
Three Months Ended |
|
|
|
Nine Months Ended |
|
|
||||
September 30, |
|
|
|
September 30, |
|
|
|||||
|
2023 |
|
2022 |
|
Change |
|
2023 |
|
2022 |
|
Change |
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Earnings |
|
|
|
|
( |
|
|
|
|
|
( |
Diluted WASO |
265.000 |
|
210.445 |
|
|
|
263.675 |
|
210.445 |
|
|
Diluted Earnings Per Share (EPS) |
|
|
|
|
( |
|
|
|
|
|
( |
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures (1) |
|
|
|
|
|
|
|
|
|||
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
( |
Adjusted EBITDA Margin |
|
|
|
|
250 bps |
|
|
|
|
|
(40) bps |
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Net Earnings |
|
|
|
|
|
|
|
|
|
|
|
Adjusted Diluted EPS |
|
|
|
|
|
|
|
|
|
|
( |
(1) The company reports its financials in accordance with |
Revenue growth accelerated to
Better program execution, favorable mix and higher volumes were all key drivers in the robust year-over-year adjusted EBITDA growth and adjusted EBITDA margin expansion for the third quarter.
Quarterly net earnings and diluted EPS were down compared to last year due to an unfavorable compare. Recall that Q3 2022 net earnings and diluted EPS contained a one-time net (after tax) gain of approximately
Strong operational performance coupled with a tax tailwind related to research and development credits drove increases to adjusted net earnings and adjusted diluted EPS in the quarter.
Both diluted EPS and adjusted diluted EPS year-over-year compares continue to reflect a significantly higher share count that resulted from our all stock merger with RADA in November 2022.
Cash Flow and Balance Sheet
Net cash flow generated by operating activities was
At quarter end, the balance sheet had
Bookings and Backlog
(Dollars in millions) |
Three Months Ended |
|
Nine Months Ended |
||||
|
September 30, |
|
September 30, |
||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
Bookings |
|
|
|
|
|
|
|
Book-to-Bill |
1.5x |
|
1.4x |
|
1.3x |
|
1.2x |
Backlog |
|
|
|
|
|
|
|
The company received
Segment Results
Advanced Sensing and Computing (“ASC”) Segment
(Dollars in millions) |
Three Months Ended |
|
|
|
Nine Months Ended |
|
|
||||||||
|
September 30, |
|
|
|
September 30, |
|
|
||||||||
|
2023 |
|
2022 |
|
Change |
|
2023 |
|
2022 |
|
Change |
||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
Adjusted EBITDA Margin |
11.1 |
% |
|
8.8 |
% |
|
230 bps |
|
9.9 |
% |
|
10.0 |
% |
|
(10) bps |
Bookings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Book-to-Bill |
1.9x |
|
1.7x |
|
|
|
1.4x |
|
1.3x |
|
|
ASC bookings were meaningfully ahead of expectations with clear demand for the company’s ground and dismounted soldier sensing, tactical communications as well as naval and ground network computing technologies. The majority of the year-over-year increase in ASC revenues were attributable to growth on naval and ground network computing as well as tactical communications programs. Net inorganic contribution from RADA was incremental to the solid organic performance of the segment. Adjusted EBITDA and adjusted EBITDA margin for the third quarter increased compared to last year as a result of better program execution, favorable mix and slightly higher volume.
Integrated Mission Systems (“IMS”) Segment
(Dollars in millions) |
Three Months Ended |
|
|
|
Nine Months Ended |
|
|
||||||||
|
September 30, |
|
|
|
September 30, |
|
|
||||||||
|
2023 |
|
2022 |
|
Change |
|
2023 |
|
2022 |
|
Change |
||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
( |
Adjusted EBITDA Margin |
12.3 |
% |
|
9.6 |
% |
|
270 bps |
|
10.4 |
% |
|
11.5 |
% |
|
(110) bps |
Bookings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Book-to-Bill |
0.8x |
|
0.8x |
|
|
|
1.2x |
|
1.2x |
|
|
IMS bookings were propelled by demand for our force protection solutions. Strong execution in our naval power and propulsion business drove the revenue growth for the segment. Additionally, the increases in adjusted EBITDA and adjusted EBITDA margin for the third quarter were driven by better program execution and higher volume coming particularly from our Columbia Class and other naval power programs.
2023 Guidance
Leonardo DRS is updating its 2023 guidance as specified in the table below:
Measure |
Current 2023 Guidance |
|
Prior 2023 Guidance |
Revenue |
|
|
|
Adjusted EBITDA |
|
|
|
Tax Rate |
|
|
|
Diluted Shares Outstanding |
266 million |
|
266 million |
Adjusted Diluted EPS |
|
|
|
The company does not provide a reconciliation of forward-looking adjusted EBITDA and adjusted diluted EPS, due to inherent difficulty in forecasting and quantifying the adjustments that are necessary to calculate such non-GAAP measures without unreasonable effort. Material changes to any one of these items could have a significant effect on future GAAP results.
Conference Call
Leonardo DRS management will host a conference call beginning at 10:00 a.m. ET on November 2, 2023 to discuss the financial results for its third quarter 2023.
A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Leonardo DRS Investor Relations website (https://investors.leonardodrs.com).
A replay of the conference call will be available on the Leonardo DRS website approximately 2 hours after the conclusion of the conference call.
About Leonardo DRS
Headquartered in
Forward-Looking Statements
In this press release, when using the terms the “company”, “DRS”, “we”, “us” and “our,” unless otherwise indicated or the context otherwise requires, we are referring to Leonardo DRS, Inc. This press release contains forward-looking statements and cautionary statements within the meaning of the Private Securities Litigation Reform Act of 1995. Some of the forward-looking statements can be identified by the use of forward-looking terms such as “believes,” “expects,” “may,” “will,” “shall,” “should,” “would,” “could,” “seeks,” “aims,” “strives,” “targets,” “projects,” “guidance,” “intends,” “plans,” “estimates,” “anticipates” or other comparable terms. Forward-looking statements include, without limitation, all matters that are not historical facts. They appear in a number of places throughout this press release and include, without limitation, statements regarding our intentions, beliefs, assumptions or current expectations concerning, among other things, financial goals, financial position, results of operations, cash flows, prospects, strategies or expectations, and the impact of prevailing economic conditions.
Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that forward-looking statements are not guarantees of future performance or outcomes and that actual performance and outcomes may differ materially from those made in or suggested by the forward-looking statements contained in this press release. In addition, even if future performance and outcomes are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods. New factors emerge from time to time that may cause our business not to develop as we expect, and it is not possible for us to predict all of them. Factors that could cause actual results and outcomes to differ from those reflected in forward-looking statements include, without limitation: disruptions or deteriorations in our relationship with the relevant agencies of the
You should read this press release completely and with the understanding that actual future results may be materially different from expectations. All forward-looking statements made in this press release are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this filing, and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, and changes in future operating results over time or otherwise.
Other risks, uncertainties and factors, including those discussed in our latest SEC filings under “Risk Factors” of our latest Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, all of which may be viewed or obtained through the investor relations section of our website https://www.leonardodrs.com, could cause our actual results to differ materially from those projected in any forward-looking statements we make. Readers should read carefully the discussion of these factors to better understand the risks and uncertainties inherent in our business and underlying any forward-looking statements.
Consolidated Statements of Earnings (Unaudited) |
|||||||||||
(Dollars in millions, except per share amounts) |
Three Months Ended |
|
Nine Months Ended |
||||||||
|
September 30, |
|
September 30, |
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||
Revenues: |
|
|
|
|
|
|
|
||||
Products |
|
|
|
|
|
|
|
|
|
|
|
Services |
52 |
|
|
54 |
|
|
139 |
|
|
203 |
|
Total revenues |
703 |
|
|
634 |
|
|
1,900 |
|
|
1,873 |
|
Cost of revenues: |
|
|
|
|
|
|
|
||||
Products |
(504 |
) |
|
(461 |
) |
|
(1,365 |
) |
|
(1,328 |
) |
Services |
(37 |
) |
|
(43 |
) |
|
(97 |
) |
|
(154 |
) |
Total cost of revenues |
(541 |
) |
|
(504 |
) |
|
(1,462 |
) |
|
(1,482 |
) |
Gross profit |
162 |
|
|
130 |
|
|
438 |
|
|
391 |
|
General and administrative expenses |
(96 |
) |
|
(101 |
) |
|
(286 |
) |
|
(261 |
) |
Amortization of intangibles |
(5 |
) |
|
(3 |
) |
|
(16 |
) |
|
(7 |
) |
Other operating (expenses) income, net |
(2 |
) |
|
350 |
|
|
(10 |
) |
|
351 |
|
Operating earnings |
59 |
|
|
376 |
|
|
126 |
|
|
474 |
|
Interest expense |
(10 |
) |
|
(9 |
) |
|
(27 |
) |
|
(27 |
) |
Other, net |
(1 |
) |
|
— |
|
|
(2 |
) |
|
— |
|
Earnings before taxes |
48 |
|
|
367 |
|
|
97 |
|
|
447 |
|
Income tax provision |
1 |
|
|
88 |
|
|
3 |
|
|
107 |
|
Net earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net earnings per share from common stock: |
|
|
|
|
|
|
|
||||
Basic earnings per share |
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share |
|
|
|
|
|
|
|
|
|
|
|
Consolidated Balance Sheets (Unaudited) |
||||||
(Dollars in millions) |
|
September 30, |
|
December 31, |
||
|
|
2023 |
|
2022 |
||
ASSETS |
|
|
|
|
||
Current assets: |
|
|
|
|
||
Cash and cash equivalents |
|
|
|
|
|
|
Accounts receivable, net |
|
200 |
|
|
166 |
|
Contract assets |
|
1,061 |
|
|
872 |
|
Inventories |
|
383 |
|
|
319 |
|
Prepaid expenses |
|
17 |
|
|
20 |
|
Other current assets |
|
32 |
|
|
24 |
|
Total current assets |
|
1,740 |
|
|
1,707 |
|
Noncurrent assets: |
|
|
|
|
||
Property, plant and equipment, net |
|
399 |
|
|
404 |
|
Intangible assets, net |
|
156 |
|
|
172 |
|
Goodwill |
|
1,236 |
|
|
1,236 |
|
Deferred tax assets |
|
87 |
|
|
66 |
|
Other noncurrent assets |
|
95 |
|
|
92 |
|
Total noncurrent assets |
|
1,973 |
|
|
1,970 |
|
Total assets |
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
||
Current liabilities: |
|
|
|
|
||
Short-term borrowings and current portion of long-term debt |
|
|
|
|
|
|
Accounts payable |
|
328 |
|
|
457 |
|
Contract liabilities |
|
258 |
|
|
233 |
|
Other current liabilities |
|
233 |
|
|
323 |
|
Total current liabilities |
|
951 |
|
|
1,042 |
|
Noncurrent liabilities: |
|
|
|
|
||
Long-term debt |
|
351 |
|
|
365 |
|
Pension and other postretirement benefit plan liabilities |
|
35 |
|
|
45 |
|
Deferred tax liabilities |
|
8 |
|
|
— |
|
Other noncurrent liabilities |
|
126 |
|
|
98 |
|
Total noncurrent liabilities |
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
||
Preferred stock, |
|
$— |
|
|
$— |
|
Common stock, |
|
3 |
|
|
3 |
|
Additional paid-in capital |
|
5,166 |
|
|
5,147 |
|
Accumulated deficit |
|
(2,880 |
) |
|
(2,974 |
) |
Accumulated other comprehensive loss |
|
(47 |
) |
|
(49 |
) |
Total shareholders' equity |
|
2,242 |
|
|
2,127 |
|
Total liabilities and shareholders' equity |
|
|
|
|
|
|
Consolidated Statements of Cash Flows (Unaudited) |
||||||
(Dollars in millions) |
|
Nine Months Ended |
||||
|
|
September 30, |
||||
|
|
2023 |
|
2022 |
||
Operating activities |
|
|
|
|
||
Net earnings |
|
|
|
|
|
|
Adjustments to reconcile net earnings to net cash used in operating activities: |
|
|
|
|
||
Depreciation and amortization |
|
63 |
|
|
48 |
|
Deferred income taxes |
|
(13 |
) |
|
10 |
|
Gain from sale of business |
|
— |
|
|
(350 |
) |
Other |
|
13 |
|
|
— |
|
Changes in assets and liabilities: |
|
|
|
|
||
Accounts receivable |
|
(34 |
) |
|
(17 |
) |
Contract assets |
|
(189 |
) |
|
(174 |
) |
Inventories |
|
(64 |
) |
|
(43 |
) |
Prepaid expenses |
|
3 |
|
|
— |
|
Other current assets |
|
(8 |
) |
|
(2 |
) |
Other noncurrent assets |
|
13 |
|
|
10 |
|
Defined benefit obligations |
|
(8 |
) |
|
(4 |
) |
Other current liabilities |
|
(82 |
) |
|
83 |
|
Other noncurrent liabilities |
|
6 |
|
|
(3 |
) |
Accounts payable |
|
(129 |
) |
|
(180 |
) |
Contract liabilities |
|
25 |
|
|
36 |
|
Net cash used in operating activities |
|
( |
) |
|
( |
) |
Investing activities |
|
|
|
|
||
Capital expenditures |
|
(42 |
) |
|
(35 |
) |
Proceeds from sales of businesses |
|
— |
|
|
483 |
|
Net cash (used in) provided by investing activities |
|
( |
) |
|
|
|
Financing activities |
|
|
|
|
||
Net decrease in third party borrowings (maturities of 90 days or less) |
|
(11 |
) |
|
(12 |
) |
Repayment of third party debt |
|
(454 |
) |
|
— |
|
Borrowings of third party debt |
|
555 |
|
|
— |
|
Repayment of related party debt |
|
— |
|
|
(640 |
) |
Borrowings from related parties |
|
— |
|
|
675 |
|
Dividend to US Holding |
|
— |
|
|
(396 |
) |
Proceeds from stock issuance |
|
8 |
|
|
— |
|
Cash outlay to reacquire equity instruments |
|
(1 |
) |
|
— |
|
Other |
|
(4 |
) |
|
(6 |
) |
Net cash provided by (used in) financing activities |
|
|
|
|
( |
) |
Net decrease in cash and cash equivalents |
|
( |
) |
|
( |
) |
Cash and cash equivalents at beginning of year |
|
306 |
|
|
240 |
|
Cash and cash equivalents at end of period |
|
47 |
|
|
63 |
|
Non-GAAP Financial Measures (Unaudited)
In addition to the results reported in accordance with
We believe the non-GAAP financial measures presented in this document will help investors understand our financial condition and operating results and assess our future prospects. We believe these non-GAAP financial measures, each of which is discussed in greater detail below, are important supplemental measures because they exclude unusual or non-recurring items as well as non-cash items that are unrelated to or may not be indicative of our ongoing operating results. Further, when read in conjunction with our GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as a tool to help make financial, operational and planning decisions. Finally, these measures are often used by analysts and other interested parties to evaluate companies in our industry by providing more comparable measures that are less affected by factors such as capital structure.
We recognize that these non-GAAP financial measures have limitations, including that they may be calculated differently by other companies or may be used under different circumstances or for different purposes, thereby affecting their comparability from company to company. In order to compensate for these and the other limitations discussed below, management does not consider these measures in isolation from or as alternatives to the comparable financial measures determined in accordance with
We define these non-GAAP financial measures as:
Adjusted EBITDA and Adjusted EBITDA Margin are defined as net earnings before income taxes, interest expense, amortization of acquired intangible assets, depreciation, deal related transaction costs, restructuring costs and other one-time non-operational events (which include non-service pension expense, legal liability accrual reversals, COVID-19 response costs and foreign exchange impacts) and gain on sale of dispositions, then in the case of adjusted EBITDA margin dividing adjusted EBITDA by revenues.
(Dollars in millions) |
Three Months Ended |
|
Nine Months Ended |
||||||||
|
September 30, |
|
September 30, |
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||
Net earnings |
|
|
|
|
|
|
|
|
|
|
|
Income tax provision |
1 |
|
|
88 |
|
|
3 |
|
|
107 |
|
Interest expense |
10 |
|
|
9 |
|
|
27 |
|
|
27 |
|
Amortization of intangibles |
5 |
|
|
3 |
|
|
16 |
|
|
7 |
|
Depreciation |
16 |
|
|
14 |
|
|
47 |
|
|
41 |
|
Deal related transaction costs |
1 |
|
|
16 |
|
|
4 |
|
|
26 |
|
Restructuring costs |
2 |
|
|
— |
|
|
10 |
|
|
— |
|
Other one-time non-operational events |
— |
|
|
(1 |
) |
|
(8 |
) |
|
— |
|
Gain on sale of dispositions |
— |
|
|
(350 |
) |
|
— |
|
|
(350 |
) |
Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA Margin |
11.7 |
% |
|
9.2 |
% |
|
10.2 |
% |
|
10.6 |
% |
Adjusted Net Earnings and Adjusted Diluted EPS are defined as net earnings excluding amortization of acquired intangible assets, deal related transaction costs, restructuring costs, other one-time non-operational events (which include non-service pension expense, legal liability accrual reversals, COVID-19 response costs and foreign exchange impacts), gain on sale of dispositions (net of taxes) and the related tax impact from net earnings, then in the case of adjusted diluted EPS dividing adjusted net earnings by the diluted weighted average shares outstanding.
(In millions, except per share amounts) |
Three Months Ended |
|
Nine Months Ended |
||||||||
September 30, |
|
September 30, |
|||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||
Net earnings |
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangibles |
5 |
|
|
3 |
|
|
16 |
|
|
7 |
|
Deal related transaction costs |
1 |
|
|
16 |
|
|
4 |
|
|
26 |
|
Restructuring costs |
2 |
|
|
— |
|
|
10 |
|
|
— |
|
Other one-time non-operational events |
— |
|
|
(1 |
) |
|
(8 |
) |
|
— |
|
Gain on sale of dispositions, net of taxes |
— |
|
|
(270 |
) |
|
— |
|
|
(270 |
) |
Tax effect of adjustments (1) |
(2 |
) |
|
(2 |
) |
|
(5 |
) |
|
(5 |
) |
Adjusted Net Earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Per share information |
|
|
|
|
|
|
|
||||
Diluted weighted average common shares |
265.000 |
|
|
210.445 |
|
|
263.675 |
|
|
210.445 |
|
|
|
|
|
|
|
|
|
||||
Diluted earnings per share |
|
|
|
|
|
|
|
|
|
|
|
Adjusted Diluted EPS |
|
|
|
|
|
|
|
|
|
|
|
(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments. |
Free Cash Flow is defined as the sum of the cash flows provided by (used in) operating activities, transaction related expenditures (net of tax), capital expenditures and proceeds from sale of assets.
|
|
|
|
|
|
|
|
||||
(Dollars in millions) |
Three Months Ended |
|
Nine Months Ended |
||||||||
|
September 30, |
|
September 30, |
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||
Net cash provided by (used in) operating activities |
|
|
|
( |
) |
|
( |
) |
|
( |
) |
Transaction related expenditures, net of tax |
1 |
|
|
14 |
|
|
17 |
|
|
19 |
|
Capital expenditures |
(15 |
) |
|
(13 |
) |
|
(42 |
) |
|
(35 |
) |
Proceeds from sales of assets |
(1 |
) |
|
— |
|
|
— |
|
|
— |
|
Free Cash Flow |
|
|
|
( |
) |
|
( |
) |
|
( |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20231102427138/en/
Investors
Steve Vather
VP, Investor Relations & Corporate Finance
+1 703 409 2906
stephen.vather@drs.com
Media
Michael Mount
VP, Communications & Public Affairs
+1 571 447 4624
mmount@drs.com
Source: Leonardo DRS, Inc.
FAQ
What are the financial results for Leonardo DRS in Q3 2023?
What contract did Leonardo DRS secure?
What updates were made to the 2023 guidance?
Who is the CEO of Leonardo DRS?
What is the book-to-bill ratio for Leonardo DRS?
What is the backlog for Leonardo DRS?
What is the diluted EPS for Leonardo DRS in Q3 2023?